Navigation Links
Leeds researchers test benefit of fish oil in bowel cancer spread
Date:7/1/2011

Researchers from the University of Leeds will carry out a series of experiments to see whether fish oil can prevent or treat the spread of bowel cancer to the liver.

The cancer scientists will test the effectiveness of pure Eicosapentaenoic Acid (EPA) - a naturally occurring omega-3 fish oil component which is widely available in mixed fish oil preparations in health stores and supermarkets nationwide.

Gastroenterologist Professor Mark Hull, based at the Leeds Institute of Molecular Medicine, University of Leeds, will use results from the initial experiments to design a future clinical trial to test the effect of pure EPA in humans at risk of or with metastatic bowel cancer.

The research is being funded by Yorkshire Cancer Research and it will hopefully back up existing evidence from a previous clinical trial from Leeds that showed that EPA may prevent large bowel polyps, the benign precursors of large bowel cancer.

"We and others have already demonstrated that EPA might have beneficial effects at a later stage after development of malignancy," said Professor Hull.

"These new tests will help us establish whether EPA can prevent the spread of large bowel cancer to the liver, the commonest site of spread and eventual cancer-related death which we call metastasis.

"The tests will also help us establish how EPA reduces growth of established liver metastases in an experimental system prior to design of the clinical trial."

The trial published last year, which involved 55 patients with the rare inherited condition Familial Adenomatous Polyposis (FAP) thought to be responsible for about one in every 100 bowel cancers, saw a significant reduction in the size and number of pre-cancerous growths, known as polyps, in those patients who took a two gram daily dose of EPA in the free fatty acid form over a six month period.

Another promising study currently being led by the Leeds team involving nearly a 1000 patients, is investigating whether taking EPA alone, or together with aspirin, can help stop pre-cancerous growths from developing in the bowel.


'/>"/>

Contact: Paula Gould
p.a.gould@leeds.ac.uk
44-133-343-8059
University of Leeds
Source:Eurekalert

Related medicine news :

1. Leeds Teaching Hospitals Trust and RSLSteeper Team Up to Help Paralympian Walk His Sister Down the Aisle
2. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
3. BUSM researchers find herbal medicine treatment reduces inflammation in allergen-induced asthma
4. Researchers at Oregon Health & Science University discover MS-like disease in monkeys
5. Drug shows improved kidney function for type 2 diabetics, UT Southwestern researchers report
6. Researchers identify components of speech recognition pathway in humans
7. Wayne State University researchers win grant from the NSF to target tinnitus
8. Researchers find CDT biomarker ineffective for identifying unhealthy alcohol use
9. Mayo Clinic researchers use human vaccine to cure prostate cancer in mice
10. UT Southwestern researchers uncover why ketamine produces a fast antidepressant response
11. Researchers report progress using iPS cells to reverse blindness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Virginia (PRWEB) , ... March 23, 2017 , ... ... public health services to their communities, 16 more public health departments have been ... week’s decisions bring another 4.5 million people into the expanding network of communities ...
(Date:3/23/2017)... , ... March 23, 2017 , ... 82% of adults are unaware of the dangers ... not brush their teeth the minimum two times a day that dentists recommend. The ramifications ... 51 million hours of school and adults missing 164 million hours of work each year ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... investment in Los Angeles based healthcare technology company California Healthcom Group (CHG). ... the US, and healthcare arena. With headquarters in California, CHG is a growing, ...
(Date:3/23/2017)... ... ... After raising more than $1.135 million ($1,479,231 AUD) from nearly 20,000 backers ... crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle USA, LLC, ... excited to be operating on U.S. shores, where most of our initial crowdfunding backers ...
(Date:3/23/2017)... ... ... According to the National Sleep Foundation , poor sleep quality affects ... of the sunken-eye look, which can include dark circles or bags under the eyes. ... likely due to genetics, dehydration, allergies, and losing fat beneath the thin skin under ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... DENVER , March 23, 2017  Drug ... pain medication misuse and deadly overdoses. A new ... Health Solutions, www.cordantsolutions.com , reports more detailed ... tests, which can potentially improve therapy adherence, patient ... The Cordant Comprehensive Oral fluid Rx Evaluation ...
(Date:3/23/2017)... , March 23, 2017  A new genetic ... accurate identification of individuals who carry HLA-B*15:02 ... a rare yet potentially deadly side effect of ... disorder.  The gene HLA-B*15:02 is strongly ... as Stevens-Johnson syndrome and toxic epidermal necrolysis in ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
Breaking Medicine Technology: